Abstract:Background: 4-[18F]fluorobenzyl-triphenylphosphonium ([18F]FBnTP) is a lipophilic cation PET tracer. The cellular uptake of [18F]FBnTP is correlated with oxidative phosphorylation by mitochondria, which has been associated with multiple critical diseases. To date, [18F]FBnTP has been successfully applied for imaging myocardial perfusion, assessment of severity of coronary artery stenosis, delineation of the ischemic area after transient coronary occlusion, and detection/quantification of apoptosis in various animal models. Recent preclinical and clinical studies have also expanded the possibilities of using [18F]FBnTP in oncological diagnosis and therapeutic monitoring. However, [18F]FBnTP is typically prepared through a tediously lengthy four-step, three-pot reaction and required multiple synthesizer modules; Thus, such an approach remains a challenge for this promising radiopharmaceutical to be implemented for routine clinical studies. Herein, we report an optimized one-step, one-pot automated approach to produce [18F]FBnTP through a single standard commercially-available radiosynthesizer that enables centralized production for clinical use. Results: The fully automated production of [18F]FBnTP took less than 55 min with radiochemical yields ranging from 28.33 ± 13.92% (non-decay corrected), apparent molar activity of 69.23 ± 45.62 GBq/µmol, and radiochemical purities of 99.79 ± 0.41%. The formulated [18F]FBnTP solution was determined to be sterile and colorless with a pH of 4.0-6.0. Our data has indicated no observable radiolysis after 8 h from the time of final product formulation and maximum assay of 7.88 GBq. Conclusions: A simplified and cGMP-compliant radiosynthesis of [18F]FBnTP has been established on the commercially available synthesizer in high activity concentration and radiochemical purity. While the preclinical and clinical studies using [18F]FBnTP PET are currently underway, the automated approaches reported herein facilitate clinical adoption of this radiotracer and warrant centralized production of [18F]FBnTP for imaging multiple patients.

A Reliable Automated Synthesis of 6-[18F]Fluoro-L-DOPA and the Clinical Application on the Imaging of Congenital Hyperinsulinism of Infants

A Reliable and Automated Synthesis of 6-[18F]fluoro-l-dopa and the Clinical Application on the Imaging of Congenital Hyperinsulinism of Infants

A New Simple Automated Synthesis of 6-F-18-dopa with Fluoride

Rapid Automated Radiosynthesis and Animal Experiments of [~(18)F]Fluoroacetate

A one-step fully automated radio-synthesis of a dopamine transporter PET imaging agent 18F-FECNT and its in vivo evaluations

Update on the Role of [18F]FDOPA PET/CT

Optimization and automation of the radiosynthesis of [18F]Lu-LuFL as a clinically useful PET ligand targeting FAP for tumor imaging

Automatic synthesis of 18F-FeCH as molecular imaging agent for tumor diagnosis

Noninvasive imaging of FAP expression using positron emission tomography: A comparative evaluation of a [18F]-labeled glycopeptide-containing FAPI with [18F]FAPI-42

Radiosynthesis and Evaluation of 4-(6-[18f]fluoro-4-(5-isopropoxy-1h-indazol-3-yl)pyridin-2-yl)morpholine As a Novel Radiotracer Candidate Targeting Leucine-Rich Repeat Kinase 2.

Novel electrophilic synthesis of 6-[18F]fluorodopamine and comprehensive biological evaluation

Automated Microfluidic Chip System for Radiosynthesis of PET Imaging Probes

Automated Synthesis of Hypoxia Imaging Agent [ 18 F]FMISO Based Upon a Modified Explora FDG 4 Module

Semi-automated Synthesis of 1-[18F]fluoroethyl-L-tryptophan

Automated synthesis of ~(18)F-fluorothymidine via Sep-Pak purification

Difluorocarbene-enabled synthesis of 18 F-radiotracers in positron emission tomography

Automated synthesis of 18F-fluoroacetate by using Explora FDG4 module

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

Radiosynthesis challenges of 11C and 18F-labeled radiotracers in the FX2C/N tracerlab and their validation through PET-MR imaging

Optimization of Precursor Synthesis Conditions of (2S,4S)4–[18F]FPArg and Its Application in Glioma Imaging

cGMP compliant one-step, one-pot automated [18F]FBnTP production for clinical imaging of mitochondrial activity